参考文献/References:
[1] Zamorano JL,Lancellotti P,Rodriguez Mu?oz D,et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology(ESC)[J]. Eur Heart J,2016,37(36):2768-2801.
[2] Awadalla M,Hassan MZO,Alvi RM,et al. Advanced imaging modalities to detect cardiotoxicity[J]. Curr Probl Cancer,2018,42(4):386-396.
[3] Reed GW,Rossi JE,Cannon CP. Acute myocardial infarction[J]. Lancet,2017,389(10065):197-210.
[4] Seemann I,Gabriels K,Visser NL,et al. Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature[J]. Radiother Oncol,2012,103(2):143-150.
[5] Houson HA,Nkepang GN,Hedrick AF,et al. Imaging of isoproterenol-induced myocardial injury with 18F labeled fluoroglucaric acid in a rat model[J]. Nucl Med Biol,2018,59:9-15.
[6] Ricchelli F,Sileikyt? J,Bernardi P. Shedding light on the mitochondrial permeability transition[J]. Biochim Biophys Acta,2011,1807(5):482-490.
[7] Janczar K,Su Z,Raccagni I,et al. The 18-kDa mitochondrial translocator protein in gliomas:from the bench to bedside[J]. Biochem Soc Trans,2015,43(4):579-585.
[8] Luo R,Wang L,Ye F,et al. [18F]FEDAC translocator protein positron emission tomography computed tomography for early detection of mitochondrial dysfunction secondary to myocardial ischemia[J]. Ann Nucl Med,2021,35(8):927-936.
[9] Sugamura K,Keaney JF Jr. Reactive oxygen species in cardiovascular disease[J]. Free Radic Biol Med,2011,51(5):978-992.
[10] Frijhoff J,Winyard PG,Zarkovic N,et al. Clinical relevance of biomarkers of oxidative stress[J]. Antioxid Redox Signal,2015,23(14):1144-1170.
[11] Wu J,Boutagy NE,Cai Z,et al. Feasibility study of PET dynamic imaging of [18F]DHMT for quantification of reactive oxygen species in the myocardium of large animals[J]. J Nucl Cardiol,2022,29(1):216-225.
[12] Teicher BA,Fricker SP. CXCL12(SDF-1)/CXCR4 pathway in cancer[J]. Clin Cancer Res,2010,16(11):2927-2931.
[13] Kircher M,Tran-Gia J,Kemmer L,et al. Imaging inflammation in atherosclerosis with CXCR4-directed 68Ga-pentixafor PET/CT:correlation with 18F-FDG PET/CT[J]. J Nucl Med,2020,61(5):751-756.
[14] Derlin T,Sedding DG,Dutzmann J,et al. Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [68Ga]pentixafor PET/CT[J]. Eur J Nucl Med Mol Imaging,2018,45(11):1934-1944.
[15] Velasco C,Mateo J,Santos A,et al. Assessment of regional pulmonary blood flow using 68GaDOTA PET[J]. EJNMMI Res,2017,7(1):7.
[16] Boughdad S,Latifyan S,Fenwick C,et al. 68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis[J]. J Immunother Cancer,2021,9(10):e003594.
[17] Ivey MJ,Tallquist MD. Defining the cardiac fibroblast[J]. Circ J,2016,80(11):2269-2276.
[18] Humeres C,Frangogiannis NG. Fibroblasts in the infarcted,remodeling,and failing heart[J]. JACC Basic Trans Sci,2019,4(3):449-467.
[19] Lindner T,Loktev A,Altmann A,et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein [J]. J Nucl Med,2018,59(9):1415-1422.
[20] Kessler L,Kupusovic J,Ferdinandus J,et al. Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI PET[J]. Clin Nucl Med,2021,46(10):807-813.
[21] Gr?nman M,Tarkia M,Kiviniemi T,et al. Imaging of αvβ3 integrin expression in experimental myocardial ischemia with [68Ga]NODAGA-RGD positron emission tomography[J]. J Transl Med,2017,15(1):144.
[22] Bentsen S,Clemmensen A,Loft M,et al. [68Ga]Ga-NODAGA-E[(cRGDyK)]2 angiogenesis PET/MR in a porcine model of chronic myocardial infarction[J]. Diagnostics(Basel),2021,11(10):1807.
[23] Larson MC,Woodliff JE,Hillery CA,et al. Phosphatidylethanolamine is externalized at the surface of microparticles[J]. Biochim Biophys Acta,2012,1821(12):1501-1507.
[24] Zhao M,Li Z. A single-step kit formulation for the 99mTc-labeling of HYNICDuramycin[J]. Nucl Med Biol,2012,39(7):1006-1011.
[25] Mullah SH,Saha BK,Abutarboush R,et al. Perfluorocarbon NVX-108 increased cerebral oxygen tension after traumatic brain injury in rats[J]. Brain Res,2016,1634:132-139.
[26] Liu Z,Barber C,Gupta A,et al. Imaging assessment of cardioprotection mediated by a dodecafluoropentane oxygen-carrier administered during myocardial infarction[J]. Nucl Med Biol,2019,70:67-77.
[27] Wysoczynski M,Solanki M,Borkowska S,et al. Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction[J]. Stem Cells,2014,32(9):2502-2515.
[28] Andreadou I,Iliodromitis EK,Lazou A,et al. Effect of hypercholesterolaemia on myocardial function,ischaemia-reperfusion injury and cardioprotection by preconditioning,postconditioning and remote conditioning[J]. Br J Pharmacol,2017,174(12):1555-1569.
[29] Sharif-Paghaleh E,Yap ML,Puhl SL,et al. Non-invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury[J]. Sci Rep,2017,7(1):16090.
[30] Thorn SL,Barlow SC,Feher A,et al. Application of hybrid matrix metalloproteinase-targeted and dynamic 201Tl single-photon emission computed tomography/computed tomography imaging for evaluation of early post-myocardial infarction remodeling[J]. Circ Cardiovasc Imaging,2019,12(11):e009055.
[31] Jung JJ,Razavian M,Challa AA,et al. Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease[J]. J Nucl Med,2015,56(6):933-938.
相似文献/References:
[1]冯泽豪 姜萌 卜军.心脏磁共振评价化疗所致心肌损伤的研究进展[J].心血管病学进展,2019,(5):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
FENG Zehao,JIANG Meng,PU Jun.Cardiovascular Magnetic Resonance for Detection of Myocardial Impairments Caused by Chemotherapy[J].Advances in Cardiovascular Diseases,2019,(1):667.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.003]
[2]李凤鹏 张军.2型心肌梗死和心肌损伤的研究进展[J].心血管病学进展,2019,(9):1275.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.023]
LI Fengpeng,ZHANG Jun.Type 2 Myocardial Infarction and Myocardial Injury[J].Advances in Cardiovascular Diseases,2019,(1):1275.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.023]
[3]布热比古力·阿布力米提 付真彦.乳腺癌药物治疗与心肌损伤[J].心血管病学进展,2020,(8):802.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.005]
Burebiguli·abulimitiFU Zhenyan.Drug Therapy of Breast Cancer and Assosiated Myocardial Damage[J].Advances in Cardiovascular Diseases,2020,(1):802.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.005]
[4]陈涛 张大勇 袁明 魏天龙.急性ST段抬高型心肌梗死患者血miRNA-499a与心肌损伤标志物的相关性分析[J].心血管病学进展,2020,(9):994.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.025]
CHEN Tao,ZHANG Dayong,YUAN Ming,et al.Correlation Between Serum miRNA-499a and Myocardial Injury Markers in Patients with Acute ST-Segment Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2020,(1):994.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.025]
[5]汪汉,刘汉雄,蔡琳.2019冠状病毒病的心血管表现[J].心血管病学进展,2020,(11):1152.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
WANG Han,LIU Hanxiong,CAI Lin.Cardiovascular Profiles in Corona V irus Disease 2019[J].Advances in Cardiovascular Diseases,2020,(1):1152.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
[6]田振宇 刘燕娥 朱丹 曹宝山 崔鸣.肿瘤化疗心肌损伤机制及其与肠道菌群相关性的研究进展[J].心血管病学进展,2023,(6):496.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.004]
TIAN Zhenyu,LIU Yane,ZHU Dan,et al.Progress of the Mechanism of Myocardial Injury and its Correlation between Tumor Chemotherapy and Intestinal Microbiota[J].Advances in Cardiovascular Diseases,2023,(1):496.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.004]
[7]袁敏?韩轩茂?蔺雪峰.纳米氧化铈抗氧化保护心肌细胞的研究进展[J].心血管病学进展,2023,(7):654.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.018]
YUAN Min,HAN Xuanmao,LIN Xuefeng.Cerium Oxide Nanoparticles in Antioxidant Protection of M yocardial?ells?/html>[J].Advances in Cardiovascular Diseases,2023,(1):654.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.018]
[8]冉黔松 周厚荣.长链非编码RNA调节自噬在心肌缺血再灌注损伤中的研究进展[J].心血管病学进展,2024,(3):238.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.011]
RAN Qiansong ZHOU Hourong.Long Non-Coding RNA Regulating Autophagy in Myocardial Ischemia-Reperfusion Injury[J].Advances in Cardiovascular Diseases,2024,(1):238.[doi:10.16806/j.cnki.issn.1004-3934.2024.03.011]
[9]富悦 任家孚 阿荣.白细胞介素-13与免疫细胞相互作用在心血管疾病中的研究进展[J].心血管病学进展,2024,(4):345.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.013]
FU Yue,REN Jiafu,A Rong.Interaction of Interleukin-13 and Immunocyte in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2024,(1):345.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.013]